Skip to main content
ImmuneCited

Garlic Upper Respiratory Tract Infections

B

A 12-week randomized controlled trial found the garlic group experienced 63% fewer colds, 70% shorter symptom duration, and significantly fewer viral-challenged days (111 vs 365) compared to placebo. While promising, human clinical trials remain limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dgarlic\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

A 12-week randomized controlled trial found the garlic group experienced 63% fewer colds, 70% shorter symptom duration, and significantly fewer viral-challenged days (111 vs 365) compared to placebo. While promising, human clinical trials remain limited.

Key Study Findings

Other n=80 3 weeks Double-blind
Investigation of the natural supplement IQP-AS-119 for the prevention of upper respiratory tract infections in …
Dose: 20.0% vs: placebo Outcome: None 効果: or 14 P=0.038

対象集団: None

Other 17.3 weeks
Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Alzheimer's disease patients

Review
Treatment of the common cold in children and adults.
Dose: None vs: None Outcome: infection rate 効果: None None

対象集団: None

Review
Chemoprevention of bladder cancer.
Dose: Various nutrients (selenium, vitamins, green tea) vs: None Outcome: Bladder cancer chemoprevention 効果: None None

対象集団: Bladder cancer patients

Meta-Analysis
Unsafe and potentially safe herbal therapies.
Dose: None vs: None Outcome: lipid levels 効果: None None

対象集団: hypertensive patients

Key Statistics

3

研究数

300

参加者数

Positive

B

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

fresh:
2-5 g raw garlic/day
general:
600-1,200 mg aged garlic extract/day

上限量: No established UL; high doses may increase bleeding risk

研究で検討された用量

用量 期間 効果 N
20.0% 3 weeks Mixed 80
None 17.3 weeks Positive --
None -- Mixed --
Various nutrients (selenium, vitamins, green tea) -- Positive --
None -- Mixed --

推奨摂取タイミング: With meals to reduce GI discomfort

Safety & Side Effects

報告されている副作用

  • Gastrointestinal discomfort (heartburn, gas, nausea)
  • Body and breath odor
  • Increased bleeding risk
  • Allergic reactions (contact dermatitis, rare)

既知の相互作用

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • HIV protease inhibitors (saquinavir — may reduce drug levels)
  • CYP2E1 substrates (garlic may alter metabolism)
  • Isoniazid (may reduce drug absorption)

耐容上限摂取量: No established UL; high doses may increase bleeding risk

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Garlic help with Upper Respiratory Tract Infections?
Based on 3 studies with 300 participants, there is moderate evidence from clinical studies that Garlic may support Upper Respiratory Tract Infections management. Our evidence grade is B (Good Evidence).
How much Garlic should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 2-5 g raw garlic/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Garlic?
Reported side effects may include Gastrointestinal discomfort (heartburn, gas, nausea), Body and breath odor, Increased bleeding risk, Allergic reactions (contact dermatitis, rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Garlic and Upper Respiratory Tract Infections?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: Upper Respiratory Tract Infections

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。